AFP and hepatocellular carcinoma: Therefore, while elevated serum AFP and PIVKA-II levels often indicate existing HCC, dynamic monitoring of ESPL1 levels, particularly in patients with values exceeding 345.7 ng/L, may provide an effective early warning for the onset of HBV-HCC.